These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 34766302)
1. Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery. Panou DA; Diedrichsen RG; Kristensen M; Nielsen HM Methods Mol Biol; 2022; 2383():371-384. PubMed ID: 34766302 [TBL] [Abstract][Full Text] [Related]
2. Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery In Vitro. Rønholt S; Kristensen M; Nielsen HM Methods Mol Biol; 2015; 1324():261-77. PubMed ID: 26202275 [TBL] [Abstract][Full Text] [Related]
3. Revealing the importance of carrier-cargo association in delivery of insulin and lipidated insulin. Diedrichsen RG; Harloff-Helleberg S; Werner U; Besenius M; Leberer E; Kristensen M; Nielsen HM J Control Release; 2021 Oct; 338():8-21. PubMed ID: 34298056 [TBL] [Abstract][Full Text] [Related]
4. Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation. Kristensen M; de Groot AM; Berthelsen J; Franzyk H; Sijts A; Nielsen HM Bioconjug Chem; 2015 Mar; 26(3):477-88. PubMed ID: 25611217 [TBL] [Abstract][Full Text] [Related]
5. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium. Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330 [TBL] [Abstract][Full Text] [Related]
7. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier. Moran GW; O'Neill C; McLaughlin JT Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889 [TBL] [Abstract][Full Text] [Related]
8. Cell-Penetrating Peptides as Carriers for Oral Delivery of Biopharmaceuticals. Kristensen M; Nielsen HM Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):99-106. PubMed ID: 26525297 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport. Kamei N; Onuki Y; Takayama K; Takeda-Morishita M J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728 [TBL] [Abstract][Full Text] [Related]
10. Effect of chitosan on epithelial cell tight junctions. Smith J; Wood E; Dornish M Pharm Res; 2004 Jan; 21(1):43-9. PubMed ID: 14984256 [TBL] [Abstract][Full Text] [Related]
11. A potential mechanism of a cationic cyclopeptide for enhancing insulin delivery across Caco-2 cell monolayers. Chang M; Li X; Sun Y; Cheng F; Li Y; Zhao W; Wang Q Biol Pharm Bull; 2013; 36(10):1602-7. PubMed ID: 23924822 [TBL] [Abstract][Full Text] [Related]
12. [Effect of self-microemulsifying system on cell tight junctions]. Sha XY; Fang XL Yao Xue Xue Bao; 2006 Jan; 41(1):30-5. PubMed ID: 16683524 [TBL] [Abstract][Full Text] [Related]
13. Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. Xu LF; Xu C; Mao ZQ; Teng X; Ma L; Sun M Arch Pharm Res; 2011 Feb; 34(2):245-51. PubMed ID: 21380808 [TBL] [Abstract][Full Text] [Related]
14. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958 [TBL] [Abstract][Full Text] [Related]
15. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606 [TBL] [Abstract][Full Text] [Related]
16. Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin. Kamei N; Kawano S; Abe R; Hirano S; Ogino H; Tamiwa H; Takeda-Morishita M Eur J Pharm Biopharm; 2020 Oct; 155():77-87. PubMed ID: 32781024 [TBL] [Abstract][Full Text] [Related]
17. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems. Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427 [TBL] [Abstract][Full Text] [Related]
18. Specifically Sized Hyaluronan (35 kDa) Prevents Ethanol-Induced Disruption of Epithelial Tight Junctions Through a layilin-Dependent Mechanism in Caco-2 Cells. Bellos DA; Sharma D; McMullen MR; Wat J; Saikia P; de la Motte CA; Nagy LE Alcohol Clin Exp Res; 2019 Sep; 43(9):1848-1858. PubMed ID: 31237689 [TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction. Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566 [TBL] [Abstract][Full Text] [Related]
20. PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. Uskoković V; Lee PP; Walsh LA; Fischer KE; Desai TA Biomaterials; 2012 Feb; 33(5):1663-72. PubMed ID: 22116000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]